AzTrials
AzTrials

Fiberoptic Intubation in ChildrenNCT01876940

Comparison of Fiberoptic Intubation With Fiberoptic Intubation Through an Air-Q Intubating Laryngeal Airway in Infants and Small Children

A study testing air-Q, followed by fiberoptic intubation and Free-hand Fiberoptic Intubation in people with Fiberoptic Intubation in Children, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this prospective randomized study is to compare the effect of operator experience on the ability to use fiberoptic-guided intubation in children less than two years old, with and without the use of an air-Q as a conduit. Read more about this study

Who is it for?
Ages 1 day to 2 yearsHealthy volunteers can take part
Conditions the study is for
Fiberoptic Intubation in Children
What is being tested?
air-Q, followed by fiberoptic intubation and Free-hand Fiberoptic Intubation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
Jun 2013to Jul 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 2 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Healthy (ASA I to III) children who will be intubated as part of their general anesthesia plan for their scheduled surgeries
  • Age 1 month - 2 years
  • Weight 1-20 Kg

Who cannot join

  • Children with active respiratory infection
  • Known history of difficult mask ventilation
  • Diagnosis of a congenital syndrome associated with difficult airway management
  • Airway abnormalities (e.g., laryngomalacia, subglottic stenosis).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: A Randomized Comparison of Free-handed Fiberoptic Intubation Compared With Fiberoptic Intubation Through an Air-QTM Intubating Laryngeal Airway in Children Less Than Two Years of Age: Does Operator Experience Affect Time to Successful Tracheal Intubation?

The goal of this prospective randomized study is to compare the effect of operator experience on the ability to use fiberoptic-guided intubation in children less than two years old, with and without the use of an air-Q as a conduit. The question the investigators are trying to answer is: Does the operator experience make a significant difference in the time for successful fiberoptic guided tracheal intubation with and without the use of an air-Q intubating laryngeal airway?

Read the detailed description

The aim of this study is to compare the effect of operator experience on the ability to use fiberoptic-guided intubation in children less than two years old, with and without the use of an air-Q as a conduit. The ease and time for placement of the air-Q, fiberoptic grade of laryngeal view, time for fiberoptic tracheal intubation, and peri-operative complications will also be assessed.

Being tested
air-Q, followed by fiberoptic intubation, Free-hand Fiberoptic Intubation
Keywords
supraglottic airway, children, tracheal intubation, fiberoptic bronchoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • air-Q, followed by fiberoptic intubationDevice

    Also called Device will be placed and fiberoptic tracheal intubation will be performed and timed. Laryngeal grade of view will also be assessed

  • Free-hand Fiberoptic IntubationDevice

    Fiberoptic tracheal intubation will be performed without use of the air-Q and timed. Laryngeal grade of view will also be assessed

Study groups in NCT01876940
Study groupRoleWhat they receive
Fiberoptic Intubation performed by an expertActive comparatorTracheal intubation will be performed by an expert anesthesia attending with and without use of the air-Q
Receives: Device: air-Q, followed by fiberoptic intubation; Device: Free-hand Fiberoptic Intubation
Fiberoptic Intubation performed by a noviceExperimentalTracheal intubation will be performed by an anesthesia trainee with and without use of the air-Q
Receives: Device: air-Q, followed by fiberoptic intubation; Device: Free-hand Fiberoptic Intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time for successful fiberoptic tracheal intubation

    The time for successful intubation will be from removal of the face mask or disconnection of the circuit from the air-Q until evidence of end-tidal CO2 is confirmed.

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Secondary outcomes (7)
  1. Time to successful placement of the Air-Q

    Successful placement of the air-Q will start with the removal of the facemask until presence of end-tidal CO2 is confirmed.

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  2. Number of attempts to place the Air-Q

    Number of attempts needed for successful placement will be recorded (maximum of 3 attempts will be considered as a failure)

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  3. Ease for placement of the air-Q

    The ease for Air-Q placement will be assessed using a subjective scale

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  4. Fiberoptic grade of laryngeal view

    The laryngeal alignment through the devices will be graded using an established scoring system

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  5. Peri-operative complications

    Includes: Complications during the placement of the Air-Q (Laryngospasm, Bronchospasm, Desaturation, etc. Oropharyngolaryngeal morbidity at discharge, participants will be followed for the duration of anesthesia and after surgery, an average of 24 hours. Oropharyngolaryngeal morbidity at 24 hours post-operatively, measured at 24 hours after device placement/study initiation. These will be assessed by the subject's response or parents subjective assesment to standardized questions regarding oropharyngeal complaints such as sore throat, jaw pain, neck discomfort.

    Measured: Measured at 24 hours after device placement/study initiation

  6. Number of attempts for fiberoptic tracheal intubation

    Number of attempts needed for successful fiberoptic tracheal intubation will be recorded (maximum of 3 attempts will be considered as a failure)

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

  7. Ease for fiberoptic tracheal intubation

    The ease for fiberoptic tracheal intubation will be assessed using a subjective scale

    Measured: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2013 (estimated)
  2. Study startJun 2013
  3. Primary completionJul 2013
  4. Study completionJul 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01876940
Sponsor's protocol ID
IRB#2013-15391
Status last verified
Jul 2013
First submitted
11 Jun 2013
Last updated
30 Jul 2013
Results posted
No
Data monitoring committee
Yes

Publications

  • Hodzovic I, Janakiraman C, Sudhir G, Goodwin N, Wilkes AR, Latto IP. Fibreoptic intubation through the laryngeal mask airway: effect of operator experience*. Anaesthesia. 2009 Oct;64(10):1066-71. doi: 10.1111/j.1365-2044.2009.06030.x.

    PubMed 19735396
  • Hodzovic I, Petterson J, Wilkes AR, Latto IP. Fibreoptic intubation using three airway conduits in a manikin: the effect of operator experience. Anaesthesia. 2007 Jun;62(6):591-7. doi: 10.1111/j.1365-2044.2007.05054.x.

    PubMed 17506738
  • Erb T, Marsch SC, Hampl KF, Frei FJ. Teaching the use of fiberoptic intubation for children older than two years of age. Anesth Analg. 1997 Nov;85(5):1037-41. doi: 10.1097/00000539-199711000-00013.

    PubMed 9356095
  • Jagannathan N, Kozlowski RJ, Sohn LE, Langen KE, Roth AG, Mukherji II, Kho MF, Suresh S. A clinical evaluation of the intubating laryngeal airway as a conduit for tracheal intubation in children. Anesth Analg. 2011 Jan;112(1):176-82. doi: 10.1213/ANE.0b013e3181fe0408. Epub 2010 Nov 16.

    PubMed 21081777

Questions about this trial

What is this clinical trial studying?

A study testing air-Q, followed by fiberoptic intubation and Free-hand Fiberoptic Intubation in people with Fiberoptic Intubation in Children, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jul 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time for successful fiberoptic tracheal intubation (time frame: Participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01876940, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in